Invicta Diagnostic Board Meeting Outcome
Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Board approved business outlook and forward-looking guidance for the 3rd AGM on 19 September 2026. Company targets consolidated revenue of ₹45–50 crore with ~25% EBITDA margin.
Invicta Diagnostic Limited announced management changes, including the appointment of Dr. Sanket Vinod Jain as Managing Director, and the divestment of its stake in MSCRIBEIT Infotech LLP.
Invicta Diagnostic Limited appointed M/s. Shrenik Nagaonkar & Associates as Secretarial Auditor for five years. This ensures statutory compliance with Companies Act and SEBI regulations.